[Congressional Record Volume 171, Number 44 (Monday, March 10, 2025)]
[Senate]
[Page S1638]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SA 1243. Mr. COONS submitted an amendment intended to be proposed by
him to the bill S. 331, to amend the Controlled Substances Act with
respect to the scheduling of fentanyl-related substances, and for other
purposes; which was ordered to lie on the table; as follows:
At the appropriate place, insert the following:
SEC. ___. ANNUAL REPORTING.
(a) Definition.--In this section, the term ``fentanyl-
related substance'' has the meaning given that term under
subsection (e) of schedule I of section 202(c) of the
Controlled Substances Act (21 U.S.C. 812(c)), as added by
this Act.
(b) Reporting.--Not later than 1 year after the date of
enactment of this Act, and every year thereafter, the
Comptroller General of the United States shall submit to
Congress a report that, for the year before the year during
which the report is submitted--
(1) indicates the number of fentanyl-related substances
identified by the Attorney General and lists the scientific
names of each newly identified fentanyl-related substance;
(2) describes the extent of scientific and medical
evaluation by the Attorney General or the Secretary of Health
and Human Services, if any, of each substance that was
determined to be a fentanyl-related substance;
(3) identifies any fentanyl-related substance for which
results of the scientific and medical evaluation, if any, by
the Secretary of Health and Human Services found the
fentanyl-related substance to have some accepted medical use
or a lower potential for abuse than substances included in
schedule I of section 202(c) of the Controlled Substances Act
(21 U.S.C. 812(c)) and, for each such fentanyl-related
substance, the control status of the substance; and
(4) for each fentanyl-related substance, indicates the
number of criminal cases in which an offense involving the
fentanyl-related substance was charged.
______